{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:12:02Z","timestamp":1780330322703,"version":"3.54.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10552-025-02121-0","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:18:32Z","timestamp":1768983512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Monitoring cancer survival in Belgium: early insights 3\u00a0years after the COVID-19 pandemic"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-8989","authenticated-orcid":false,"given":"Tim","family":"Tambuyzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8604-8097","authenticated-orcid":false,"given":"Bart","family":"Van Gool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4788-968X","authenticated-orcid":false,"given":"Liesbet","family":"Van Eycken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2031-984X","authenticated-orcid":false,"given":"Harlinde","family":"De Schutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"2121_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10552-020-01351-8","volume":"31","author":"JJ Liu","year":"2020","unstructured":"Liu JJ (2020) The role of COVID-19 prevalence and cancer preparedness on cancer statistics in the Asia-Pacific region. Cancer Causes Control 31:1049\u20131050. https:\/\/doi.org\/10.1007\/s10552-020-01351-8","journal-title":"Cancer Causes Control"},{"key":"2121_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10654-022-00946-6","volume":"38","author":"M Angelini","year":"2023","unstructured":"Angelini M, Teglia F, Astolfi L, Casolari G, Boffetta P (2023) Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis. Eur J Epidemiol 38:31\u201338. https:\/\/doi.org\/10.1007\/s10654-022-00946-6","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"2121_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100197","volume":"6","author":"HM Peacock","year":"2021","unstructured":"Peacock HM, Tambuyzer T, Verdoodt F, Calay F, Poirel HA, De Schutter H, Francart J, Van Damme N, Van Eycken L (2021) Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis. ESMO Open 6(4):100197. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100197","journal-title":"ESMO Open"},{"issue":"6","key":"2121_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1470-2045(20)30265-5","volume":"21","author":"AG Dinmohamed","year":"2020","unstructured":"Dinmohamed AG, Visser O, Verhoeven RH, Louwman MW, Van Nederveen FH, Willems SM, Merkx MA, Lemmens VEP, Nagtegaal ID, Siesling S (2020) Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol 21(6):750\u2013751. https:\/\/doi.org\/10.1016\/S1470-2045(20)30265-5","journal-title":"Lancet Oncol"},{"key":"2121_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2147\/CLEP.S463160","volume":"16","author":"NL Barclay","year":"2024","unstructured":"Barclay NL, Burkard T, Burn E, Delmestri A, Miquel Dominguez A, Golozar A, Guarner-Argente C, Avil\u00e9s-Jurado FX, Man WY, Rosell\u00f3 Serrano \u00c0, Rosen AW, Tan EH, Tietzova I, Prieto Alhambra D, Newby D, OPTIMA Consortium (2024) The impact of the COVID-19 pandemic on incidence and short-term survival for common solid tumours in the United Kingdom: a cohort analysis. Clin Epidemiol 16:417\u2013429. https:\/\/doi.org\/10.2147\/CLEP.S463160","journal-title":"Clin Epidemiol"},{"key":"2121_CR6","unstructured":"Statbel, the Belgian Statistical Office. https:\/\/statbel.fgov.be\/en. Accessed 30 Aug 2024."},{"key":"2121_CR7","unstructured":"Nederlandse Kankerregistratie (NKR), IKNL. https:\/\/nkr-cijfers.iknl.nl. Accessed 14 Dec 2025"},{"issue":"10","key":"2121_CR8","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/ijc.34847","volume":"154","author":"D Bennett","year":"2024","unstructured":"Bennett D, Murray I, Mitchell H, Gavin A, Donnelly D (2024) Impact of COVID-19 on cancer incidence, presentation, diagnosis, treatment and survival in Northern Ireland. Int J Cancer 154(10):1731\u20131744. https:\/\/doi.org\/10.1002\/ijc.34847","journal-title":"Int J Cancer"},{"issue":"7","key":"2121_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/ijc.35001","volume":"155","author":"HM Peacock","year":"2024","unstructured":"Peacock HM, Van Meensel M, Van Gool B, Silversmit G, Dekoninck K, Brierley JD, Van Eycken L (2024) Cancer incidence, stage shift and survival during the 2020 COVID-19 pandemic: a population-based study in Belgium. Int J Cancer 155(7):1212\u20131224. https:\/\/doi.org\/10.1002\/ijc.35001","journal-title":"Int J Cancer"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02121-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-02121-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02121-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T04:21:28Z","timestamp":1770610888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-02121-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-02121-0","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical Committee approval for this study was not necessary, based on the following facts: 1. This study was performed within the legal framework of the Belgian Cancer Registry (BCR). Based on the Coordinated Law of 10 May 2015 (art. 138); BCR has a legal task to collect data on cancer, subject it to quality control, process and analyse it, encrypt and store it, report on it, make it accessible for research, and protect it. Its activities are monitored and evaluated by the Advisory Committee of Users, an independent committee whose duly qualified members are appointed by law. 2. This retrospective study does not fall under the Belgian Law of 7 May 2004 regarding experiments on human persons (art. 3, \u00a72). The research on human data for this study was performed in compliance with the general principles of the Helsinki Declaration and applicable national guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed Consents were not obtained for this study, based on the following argument: The data controller shall be exempt from the obligation to disclose information to the persons whose data are processed (and to collect their consent) where a notification to the data subject is impossible or takes disproportionate effort, and in particular when data are processed for statistical purposes or for historical or scientific research (see. Art. 14.5, b. GDPR EU 2016\/67).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"36"}}